首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   24162篇
  免费   1827篇
  国内免费   49篇
耳鼻咽喉   238篇
儿科学   872篇
妇产科学   656篇
基础医学   3048篇
口腔科学   307篇
临床医学   3442篇
内科学   4642篇
皮肤病学   288篇
神经病学   1935篇
特种医学   735篇
外国民族医学   1篇
外科学   2222篇
综合类   761篇
一般理论   40篇
预防医学   3016篇
眼科学   619篇
药学   1235篇
中国医学   12篇
肿瘤学   1969篇
  2022年   153篇
  2021年   389篇
  2020年   266篇
  2019年   386篇
  2018年   409篇
  2017年   311篇
  2016年   370篇
  2015年   473篇
  2014年   601篇
  2013年   1005篇
  2012年   1461篇
  2011年   1524篇
  2010年   719篇
  2009年   705篇
  2008年   1354篇
  2007年   1492篇
  2006年   1468篇
  2005年   1497篇
  2004年   1441篇
  2003年   1374篇
  2002年   1292篇
  2001年   394篇
  2000年   350篇
  1999年   401篇
  1998年   288篇
  1997年   274篇
  1996年   246篇
  1995年   268篇
  1994年   212篇
  1993年   201篇
  1992年   332篇
  1991年   288篇
  1990年   271篇
  1989年   291篇
  1988年   254篇
  1987年   219篇
  1986年   223篇
  1985年   220篇
  1984年   223篇
  1983年   214篇
  1982年   147篇
  1981年   165篇
  1980年   155篇
  1979年   194篇
  1978年   133篇
  1977年   120篇
  1976年   124篇
  1974年   111篇
  1973年   110篇
  1972年   103篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed.  相似文献   
3.
4.
ABSTRACT

Measuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised.  相似文献   
5.
ABSTRACT

This work collates data from the analysis of complex mixtures analysed in STRmix during routine no-suspect volume crime work. It interrogates the upload rate for these types of mixtures and which component of the profile has been able to be interpreted for upload. The number of profiles giving multiple uploads and the amount of replicate PCR analysis has been collated.  相似文献   
6.
7.
8.
9.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号